Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Cryopreservation of in vitro matured oocytes after ex vivo oocyte retrieval from gynecologic cancer patients undergoing radical surgery

  • Park, Chan Woo (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Lee, Sun Hee (Laboratory of Reproductive Biology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Yang, Kwang Moon (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Lee, In Ho (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Lim, Kyung Teak (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Lee, Ki Heon (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Kim, Tae Jin (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine)
  • Received : 2016.02.25
  • Accepted : 2016.04.14
  • Published : 2016.06.23
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The aim of this study was to report a case series of in vitro matured (IVM) oocyte freezing in gynecologic cancer patients undergoing radical surgery under time constraints as an option for fertility preservation (FP). Methods: Case series report. University-based in vitro fertilization center. Six gynecologic cancer patients who were scheduled to undergo radical surgery the next day were referred for FP. The patients had endometrial (n=2), ovarian (n=3), and double primary endometrial and ovarian (n=1) cancer. Ex vivo retrieval of immature oocytes from macroscopically normal ovarian tissue was followed by mature oocyte freezing after IVM or embryo freezing with intracytoplasmic sperm injection. Results: A total of 53 oocytes were retrieved from five patients, with a mean of 10.6 oocytes per patient. After IVM, a total of 36 mature oocytes were obtained, demonstrating a 67.9% maturation rate. With regard to the ovarian cancer patients, seven IVM oocytes were frozen from patient 3, who had stage IC cancer, whereas one IVM oocyte was frozen from patient 4, who had stage IV cancer despite being of a similar age. With regard to the endometrial cancer patients, 15 IVM oocytes from patient 1 were frozen. Five embryos were frozen after the fertilization of IVM oocytes from patient 6. Conclusion: Immature oocytes can be successfully retrieved ex vivo from macroscopically normal ovarian tissue before radical surgery. IVM oocyte freezing provides a possible FP option in patients with advanced-stage endometrial or ovarian cancer without the risk of cancer cell spillage or time delays.

Keywords

References

  1. American Cancer Society. Cancer facts and figures 2010 [Internet]. Atlanta: American Cancer Society; 2010 [cited Sep 2014]. Available from: http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf.
  2. Makar AP, Trope C. Fertility preservation in gynecologic cancer. Acta Obstet Gynecol Scand 2001;80:794-802. https://doi.org/10.1034/j.1600-0412.2001.080009794.x
  3. Gershenson DM. Fertility-sparing surgery for malignancies in women. J Natl Cancer Inst Monogr 2005;(34):43-7.
  4. Rasool N, Rose PG. Fertility-preserving surgical procedures for patients with gynecologic malignancies. Clin Obstet Gynecol 2010;53:804-14. https://doi.org/10.1097/GRF.0b013e3181f97d02
  5. Noyes N, Knopman JM, Long K, Coletta JM, Abu-Rustum NR. Fertility considerations in the management of gynecologic malignancies. Gynecol Oncol 2011;120:326-33. https://doi.org/10.1016/j.ygyno.2010.09.012
  6. National Institutes of Health. SEER cancer statistics [Internet]. Bethesda: National Institutes of Health; [cited Sep 2014]. Available from: http://seer.cancer.gov .
  7. Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv 2007;62:58-72. https://doi.org/10.1097/01.ogx.0000251029.93792.5d
  8. Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008;89:567-72. https://doi.org/10.1016/j.fertnstert.2007.03.090
  9. Revel A, Safran A, Benshushan A, Shushan A, Laufer N, Simon A. In vitro maturation and fertilization of oocytes from an intact ovary of a surgically treated patient with endometrial carcinoma: case report. Hum Reprod 2004;19:1608-11. https://doi.org/10.1093/humrep/deh241
  10. Fadini R, Dal Canto M, Mignini Renzini M, Milani R, Fruscio R, Cantu MG, et al. Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer. J Assist Reprod Genet 2012;29:779-81. https://doi.org/10.1007/s10815-012-9768-0
  11. Prasath EB, Chan ML, Wong WH, Lim CJ, Tharmalingam MD, Hendricks M, et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod 2014;29:276-8. https://doi.org/10.1093/humrep/det420
  12. Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril 2013;99:37-43. https://doi.org/10.1016/j.fertnstert.2012.09.028
  13. Higashi M, Kajiyama H, Shibata K, Mizuno M, Mizuno K, Hosono S, et al. Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types. Gynecol Oncol 2011;123:474-8. https://doi.org/10.1016/j.ygyno.2011.08.036
  14. Lawrenz B, Fehm T, von Wolff M, Soekler M, Huebner S, Henes J, et al. Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma: evaluation by using antimullerian hormone and retrieved oocytes. Fertil Steril 2012;98:141-4. https://doi.org/10.1016/j.fertnstert.2012.04.021
  15. Ebbel E, Katz A, Kao CN, Cedars M. Reproductive aged women with cancer have a lower antral follicle count than expected. Fertil Steril 2011;96:S199-200.
  16. Frattarelli JL, Levi AJ, Miller BT, Segars JH. A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertil Steril 2003;80:350-5. https://doi.org/10.1016/S0015-0282(03)00664-2
  17. Friedler S, Koc O, Gidoni Y, Raziel A, Ron-El R. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril 2012;97:125-33. https://doi.org/10.1016/j.fertnstert.2011.10.014
  18. Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1986;1:81-7. https://doi.org/10.1093/oxfordjournals.humrep.a136365
  19. Lass A, Silye R, Abrams DC, Krausz T, Hovatta O, Margara R, et al. Follicular density in ovarian biopsy of infertile women: a novel method to assess ovarian reserve. Hum Reprod 1997;12:1028-31. https://doi.org/10.1093/humrep/12.5.1028
  20. Chian RC, Gilbert L, Huang JY, Demirtas E, Holzer H, Benjamin A, et al. Live birth after vitrification of in vitro matured human oocytes. Fertil Steril 2009;91:372-6. https://doi.org/10.1016/j.fertnstert.2007.11.088
  21. Chian RC, Huang JY, Gilbert L, Son WY, Holzer H, Cui SJ, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril 2009;91:2391-8. https://doi.org/10.1016/j.fertnstert.2008.04.014
  22. Lee S, Ozkavukcu S, Heytens E, Moy F, Oktay K. Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol 2010;28:4683-6. https://doi.org/10.1200/JCO.2010.30.5748
  23. von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2009;92:1360-5. https://doi.org/10.1016/j.fertnstert.2008.08.011
  24. Bedoschi GM, de Albuquerque FO, Ferriani RA, Navarro PA. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. J Assist Reprod Genet 2010;27:491-4. https://doi.org/10.1007/s10815-010-9429-0
  25. Sonmezer M, Turkcuoglu I, Coskun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril 2011;95:2125.e9-11.
  26. Nayak SR, Wakim AN. Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation. Fertil Steril 2011;96:e51-4. https://doi.org/10.1016/j.fertnstert.2011.04.079
  27. Huang JY, Chian RC, Gilbert L, Fleiszer D, Holzer H, Dermitas E, et al. Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: a novel strategy of fertility preservation for breast cancer patients. Am J Surg 2010;200:177-83. https://doi.org/10.1016/j.amjsurg.2009.04.004
  28. Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian RC, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online 2010;21:566-71. https://doi.org/10.1016/j.rbmo.2010.05.003
  29. Mandelbaum J, Anastasiou O, Levy R, Guerin JF, de Larouziere V, Antoine JM. Effects of cryopreservation on the meiotic spindle of human oocytes. Eur J Obstet Gynecol Reprod Biol 2004;113 Suppl 1:S17-23. https://doi.org/10.1016/j.ejogrb.2003.11.005
  30. Fasano G, Demeestere I, Englert Y. In-vitro maturation of human oocytes: before or after vitrification? J Assist Reprod Genet 2012;29:507-12. https://doi.org/10.1007/s10815-012-9751-9

Cited by

  1. Current state and controversies in fertility preservation in women with breast cancer vol.8, pp.3, 2016, https://doi.org/10.5306/wjco.v8.i3.241
  2. In vitro maturation of human immature oocytes for fertility preservation and research material vol.16, pp.3, 2016, https://doi.org/10.1002/rmb2.12042
  3. Fertility Preservation: Current and Future Perspectives for Oncologic Patients at Risk for Iatrogenic Premature Ovarian Insufficiency vol.2018, pp.None, 2016, https://doi.org/10.1155/2018/6465903
  4. Successful in vitro maturation for urgent fertility preservation despite hormonal contraception by continuous progestin application vol.35, pp.4, 2016, https://doi.org/10.1080/09513590.2018.1531985
  5. Improving the maturation rate of human oocytes collected ex vivo during the cryopreservation of ovarian tissue vol.37, pp.4, 2016, https://doi.org/10.1007/s10815-020-01724-7
  6. Cryopreservation of euploid blastocysts obtained after fertilization of in vitro matured ovarian tissue oocytes: a case report vol.37, pp.4, 2016, https://doi.org/10.1007/s10815-020-01729-2
  7. Fertility‐sparing treatment for early‐stage epithelial ovarian cancer: Contemporary oncologic, reproductive and endocrinologic perspectives vol.46, pp.8, 2016, https://doi.org/10.1111/jog.14302
  8. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes vol.35, pp.9, 2016, https://doi.org/10.1093/humrep/deaa175
  9. Fertility preservation in ovarian cancer patients vol.37, pp.6, 2016, https://doi.org/10.1080/09513590.2021.1872534
  10. In Vitro Maturation of Oocytes Retrieved from Ovarian Tissue: Outcomes from Current Approaches and Future Perspectives vol.10, pp.20, 2016, https://doi.org/10.3390/jcm10204680